查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762471

全球富血小板血浆（PRP）市场：市场规模、占有率、趋势、产业分析（依类型、应用、最终用途和地区）、未来预测（2025-2034）

Platelet Rich Plasma (PRP) Market Size, Share, Trends, & Industry Analysis Report By Type (Pure, Leukocyte, Pure Platelet-Rich Fibrin), By Application, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 113 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到2034年，全球富血小板血浆（PRP）市场规模将达到 28.5798亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

富血小板血浆（PRP）是再生医学和治疗领域的关键组成部分，彻底改变了组织修復和癒合的方法。 PRP 源自于患者自身血液，与传统疗法相比具有许多优势，包括降低过敏反应风险和加速復原时间。 PRP 的安全性、有效性和天然癒合特性推动了其需求的成长，使其成为骨科、皮肤科、运动医学和医学美容领域越来越受欢迎的选择。

由于科学的持续进步和临床需求的不断成长，PRP 市场迅速扩张。全球各国政府正透过资金、研究经费和优惠法规支持再生医学，鼓励基于 PRP 的疗法的开发和应用。这些因素加速 PRP 疗法在组织修復和肌肉骨骼癒合等领域的应用。此外，骨关节炎、肌腱损伤和脱髮等慢性疾病的盛行率不断上升，这些疾病通常与人口老化和生活方式的改变有关，这进一步刺激了对 PRP 的需求。 PRP 能够进一步促进组织再生和癒合，使其成为临床和美容应用中的宝贵工具。

整形外科医生和皮肤科医生日益采用 PRP 疗法来增强皮肤体积、肤色和质地，这是市场成长的主要推动因素。美国整形外科医师协会报告指出，作为2023年最热门的微创手术，光在美国就有约 590万例重建手术。

富血小板血浆市场：分析概论

依类型，纯富血小板血浆（P-PRP）或无白血球富血小板血浆在2024年占据了富血小板血浆市场占有率的主导地位。这得益于其独特的优势，即最大限度地降低风险和副作用，并减少治疗期间与过敏和免疫反应相关的担忧。

依应用，皮肤科领域在2024年占据了最大的占有率。这种快速成长是由对非手术美容程序（例如皮肤年轻化、痤疮疤痕治疗和头髮再生）日益成长的需求所推动的。人们对美容疗程的认识不断提高，以及 PRP 在改善皮肤纹理和促进头髮生长方面的日益普及，对这一成长做出了重大贡献。皮肤科医生使用 PRP 来治疗各种皮肤疾病，扩大了他们的治疗选择。

2024年，北美占据了全球富血小板血浆市场的收入占有率。该市场的主要驱动力包括不断成长的整容手术需求、骨科手术的普及以及运动相关损伤发生率的上升。此外，微针疗法除了最初的皮肤嫩肤应用外，还因其透皮给药等各种应用而日益普及。

由于PRP疗法在肌肉骨骼损伤治疗中的广泛应用，欧洲富血小板血浆市场经历显着成长。跟腱病、足底筋膜炎和网球肘等疾病的流行尤其助长了这一成长趋势。

全球主要参与者包括Vivostat、Arthrex Inc.、RegenOrthoSport和Dr. PRP USA LLC、Juventix Regenerative Medical, LLC、Terumo Cardiovascular Systems Corporation、Zimmer Biomet、Isto Biologics、Apex Biologix、Regen Lab SA。

目录

第1章 简介

第2章 执行摘要

第3章 分析方法

第4章 市场洞察

  • 富血小板血浆（PRP）：产业概览
  • 价值链分析
    • 富血小板血浆（PRP）市场动态
    • 驱动因素和机会
      • 美容外科和皮肤科对 PRP 的需求不断成长
      • 老年人口的增加、非骨科和运动伤害发生率的上升将在预测期内加速对 PRP 的需求
    • 限制因素和挑战
      • 高成本PRP 疗法及偿付政策 缺乏政策可能会阻碍市场成长
  • 波特五力分析
    • 替代品威胁：（低至中）
    • 新进入者威胁：（中至高）
    • 买方议价能力：（低至中）
    • 供应商议价能力：（中至高）
    • 竞争敌对：（中至高）
  • PESTLE 分析
  • COVID-19 影响分析及产业趋势

第5章 富血小板血浆市场评估（依类型）

  • 关键分析结果
  • 纯富血小板血浆（P-PRP）
  • L-PRP 血浆
  • 纯富血小板纤维蛋白（P-PRF）
  • L-PRF 纤维蛋白

第6章 富血小板血浆（PRP）市场应用评估

  • 简介
  • 骨科
  • 运动医学
  • 一般外科
  • 皮肤科
  • 眼科
  • 神经科
  • 心臟科
  • 其他

第7章 富血小板血浆（PRP）市场最终用途评估

  • 简介
  • 医院
  • 诊所
  • 其他

第8章 富血小板血浆（PRP）市场各地区评估

  • 简介
  • 北美美洲
    • 北美富血小板血浆（PRP）市场（依类型）
    • 北美富血小板血浆（PRP）市场（依应用）
    • 依最终用途
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲富血小板血浆（PRP）市场（依类型）
    • 欧洲富血小板血浆（PRP）市场（依应用）
    • 依最终用途
    • 法国
    • 德国
    • 英国
    • 义大利
    • 荷兰
    • 西班牙
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 亚太地区富血小板血浆（PRP）市场（依类型）
    • 亚太地区富血小板血浆（PRP）市场（依应用）
    • 依最终用途应用
    • 日本
    • 中国
    • 印度
    • 马来西亚
    • 印尼
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 拉丁美洲
    • 拉丁美洲富血小板血浆（PRP）市场（依类型）
    • 拉丁美洲富血小板血浆（PRP）市场（依应用）
    • 依最终用途
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 中东和非洲富血小板血浆（PRP）市场（依类型）
    • 中东和非洲富血小板血浆（PRP）市场（依应用）
    • 依最终用途
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区非洲

第9章 竞争格局

  • 市场参与者：分类
  • 战略框架
  • 供应商格局
  • 战略分类
    • 上市/核准/开发

第10章 公司简介

  • Vivostat
  • Arthrex, Inc.
  • RegenOrthoSport
  • Dr PRP USA LLC
  • Juventix Regenerative Medical, LLC.
  • Terumo Cardiovascular Systems Corporation
  • Zimmer Biomet
  • Isto Biologics
  • APEX Biologix
  • Regen Lab SA
Product Code: PM5030

The global platelet rich plasma (PRP) market size is expected to reach USD 2,857.98 million by 2034, according to a new study by Polaris Market Research. The report "Platelet Rich Plasma (PRP) Market Size, Share, Trends, & Industry Analysis Report By Type (Pure, Leukocyte, Pure Platelet-Rich Fibrin), By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Platelet rich plasma (PRP) is a key component in the field of regenerative medicine and therapeutic treatments, significantly transforming approaches in tissue repair and healing. Derived from a patient's own blood, PRP offers several advantages over conventional treatment methods, such as reduced risk of allergic reactions and faster recovery times. The growing demand for PRP is fueled by its safety, effectiveness, and natural healing properties, making it an increasingly preferred option across orthopedics, dermatology, sports medicine, and medical aesthetic procedures.

The PRP market is expanding rapidly due to ongoing scientific advancements and increasing demand in real world clinical settings. Government worldwide is supporting regenerative medicine through funding, research grants, and favorable regulations which is encouraging the development and adoption of PRP based treatments. Therefore, these factors have accelerated the usage of PRP therapies in areas such as tissue repair and musculoskeletal healing. Additionally, the growing prevalence of chronic conditions such as osteoarthritis, tendon injuries, and hair loss, which are often linked to aging populations and lifestyle changes, is further fueling demand for PRP. PRP further promotes tissue regeneration and healing, making it a valuable tool in both clinical and cosmetic applications.

The growing adoption of PRP treatments by plastic surgeons and dermatologists to enhance skin volume, tone, and texture has contributed significantly to the growth of the market. As the top minimally invasive procedure of 2023, the American Society of Plastic Surgeons reported nearly 5.9 million reconstructive procedures in the US alone.

Platelet Rich Plasma Market Report Highlights

Based on type, the pure platelet-rich plasma (P-PRP) or leukocyte-poor platelet-rich plasma segment dominated the platelet rich plasma market share in 2024, due to its distinct advantage with minimal risk and adverse effects, reducing concerns related to allergies and immune responses during treatments.

By application, the dermatology segment accounted for the largest share in 2024. The rapid growth is attributed to the growing demand for nonsurgical cosmetic surgery, such as skin rejuvenation, acne scar treatment, and hair restoration. Increased awareness of aesthetic treatments and the rising popularity of PRP for improving skin texture and hair growth significantly contributed to this growth. Dermatologists are using PRP to address diverse skin conditions, expanding treatment options.

North America dominated the global platelet rich plasma market revenue share in 2024. This market is primarily driven by increasing demand for cosmetic surgeries, a high prevalence of orthopedic procedures, and a rising incidence of sports-related injuries. Furthermore, micro-needling is gaining popularity for various applications, including transcutaneous drug administration, in addition to its original intended use for skin rejuvenation.

The platelet rich plasma market in Europe is experiencing significant growth, owing to the widespread adoption of PRP therapy for the treatment of musculoskeletal injuries. Conditions such as Achilles tendinopathy, plantar fasciitis, and tennis elbow are particularly contributing to this upward trend.

A few global key market players are Vivostat; Arthrex Inc.; RegenOrthoSport; Dr. PRP USA LLC; Juventix Regenerative Medical, LLC; Terumo Cardiovascular Systems Corporation; Zimmer Biomet; Isto Biologics; Apex Biologix; and Regen Lab SA.

Polaris Market Research has segmented the platelet rich plasma market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue, USD Million, 2020-2034)

Pure Platelet-Rich Plasma (P-PRP)

Leukocyte-and Platelet-Rich Plasma (L-PRP)

Pure Platelet-Rich Fibrin (P-PRF) - or Leukocyte-Poor Platelet-Rich Fibrin

Leukocyte- and Platelet-Rich Fibrin (L-PRF)

By Application Outlook (Revenue, USD Million, 2020-2034)

Orthopedics

Sports Medicine

General Surgery

Dermatology

Ophthalmology

Neurology

Cardiology

Others

By End Use Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Clinics

Others

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Malaysia

Australia

Indonesia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

Chapter 1. Introduction

  • 1.1 Report Description
    • 1.1.1 Objective of the Study
    • 1.1.2 Market Scope
    • 1.1.3 Assumptions
  • 1.2 Stakeholders

Chapter 2. Research Methodology

  • 2.1 Research Methodology
  • 2.2 Research Scope and Assumptions
  • 2.3 Information Procurement
    • 2.3.1 Purchased Database
    • 2.3.2 Internal Database
    • 2.3.3 Secondary Sources
    • 2.3.4 Third Party Perspective
    • 2.3.5 Primary Research
  • 2.4 Information Analysis
    • 2.4.1 Data Analysis Models
  • 2.5 Market Formulation and Data Visualization
  • 2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

  • 4.1 Platelet Rich Plasma (PRP) - Industry snapshot
  • 4.2 Platelet Rich Plasma (PRP) Market - Value Chain Analysis
    • 4.2.1 Platelet Rich Plasma (PRP) Market Dynamics
    • 4.2.2 Drivers and Opportunities
      • 4.2.2.1 Rise in demand of PRP in cosmetic surgeries and dermatology
      • 4.2.2.2 Increasing geriatric population, and rise in the occurrence of orthopaedic and sports injuries accelerate the PRP demand over the forecast period
    • 4.2.3 Restraints and Challenges
      • 4.2.3.1 High cost of PRP therapy and lack of reimbursement policy may hamper the market growth
  • 4.3 Platelet Rich Plasma (PRP) Market - Porter's Five Forces
    • 4.3.1 Threat of Substitutes: (Low to Moderate)
    • 4.3.2 Threat of New Entrants: (Moderate to high)
    • 4.3.3 Bargaining power of buyers: (Low to Moderate)
    • 4.3.4 Bargaining power of suppliers: (Moderate to High)
    • 4.3.5 Competitive Rivalry: (Moderate to High)
  • 4.4 Platelet Rich Plasma (PRP) Market - PESTLE Analysis
  • 4.5 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Platelet Rich Plasma (PRP) Market Assessment by Type

  • 5.1 Introduction
  • 5.2 Pure Platelet-Rich Plasma (P-PRP)
  • 5.3 Leukocyte-and Platelet-Rich Plasma (L-PRP)
  • 5.4 Pure Platelet-Rich Fibrin (P-PRF)
  • 5.5 Leukocyte- and Platelet-Rich Fibrin (L-PRF)

Chapter 6. Platelet Rich Plasma (PRP) Market Assessment by Application

  • 6.1 Introduction
  • 6.2 Orthopedics
  • 6.3 Sports Medicine
  • 6.4 General Surgery
  • 6.5 Dermatology
  • 6.6 Ophthalmology
  • 6.7 Neurology
  • 6.8 Cardiology
  • 6.9 Others

Chapter 7. Platelet Rich Plasma (PRP) Market Assessment by End-Use

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Others

Chapter 8. Platelet Rich Plasma (PRP) Market Assessment by Region

  • 8.1 Introduction
  • 8.2 Platelet Rich Plasma (PRP) Market - North America
    • 8.2.1 North America Platelet Rich Plasma (PRP), By Type
    • 8.2.2 North America Platelet Rich Plasma (PRP), By Application
    • 8.2.3 North America Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.2.4 Platelet Rich Plasma (PRP) Market - U.S.
      • 8.2.4.1 U.S. Platelet Rich Plasma (PRP), By Type
      • 8.2.4.2 U.S. Platelet Rich Plasma (PRP), By Application
      • 8.2.4.3 U.S. Platelet Rich Plasma (PRP), By End-Use
    • 8.2.5 Platelet Rich Plasma (PRP) Market - Canada
      • 8.2.5.1 Canada Platelet Rich Plasma (PRP), By Type
      • 8.2.5.2 Canada Platelet Rich Plasma (PRP), By Application
      • 8.2.5.3 Canada Platelet Rich Plasma (PRP), By End-Use
  • 8.3 Platelet Rich Plasma (PRP) Market - Europe
    • 8.3.1 Europe Platelet Rich Plasma (PRP), By Type
    • 8.3.2 Europe Platelet Rich Plasma (PRP), By Application
    • 8.3.3 Europe Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.3.4 Platelet Rich Plasma (PRP) Market - France
      • 8.3.4.1 France Platelet Rich Plasma (PRP), By Type
      • 8.3.4.2 France Platelet Rich Plasma (PRP), By Application
      • 8.3.4.3 France Platelet Rich Plasma (PRP), By End-Use
    • 8.3.5 Platelet Rich Plasma (PRP) Market - Germany
      • 8.3.5.1 Germany Platelet Rich Plasma (PRP), By Type
      • 8.3.5.2 Germany Platelet Rich Plasma (PRP), By Application
      • 8.3.5.3 Germany Platelet Rich Plasma (PRP), By End-Use
    • 8.3.6 Platelet Rich Plasma (PRP) Market - UK
      • 8.3.6.1 UK Platelet Rich Plasma (PRP), By Type
      • 8.3.6.2 UK Platelet Rich Plasma (PRP), By Application
      • 8.3.6.3 UK Platelet Rich Plasma (PRP), By End-Use
    • 8.3.7 Platelet Rich Plasma (PRP) Market - Italy
      • 8.3.7.1 Italy Platelet Rich Plasma (PRP), By Type
      • 8.3.7.2 Italy Platelet Rich Plasma (PRP), By Application
      • 8.3.7.3 Italy Platelet Rich Plasma (PRP), By End-Use
    • 8.3.8 Platelet Rich Plasma (PRP) Market - Netherlands
      • 8.3.8.1 Netherlands Platelet Rich Plasma (PRP), By Type
      • 8.3.8.2 Netherlands Platelet Rich Plasma (PRP), By Application
      • 8.3.8.3 Netherlands Platelet Rich Plasma (PRP), By End-Use
    • 8.3.9 Platelet Rich Plasma (PRP) Market - Spain
      • 8.3.9.1 Spain Platelet Rich Plasma (PRP), By Type
      • 8.3.9.2 Spain Platelet Rich Plasma (PRP), By Application
      • 8.3.9.3 Spain Platelet Rich Plasma (PRP), By End-Use
    • 8.3.10 Platelet Rich Plasma (PRP) Market - Russia
      • 8.3.10.1 Russia Platelet Rich Plasma (PRP), By Type
      • 8.3.10.2 Russia Platelet Rich Plasma (PRP), By Application
      • 8.3.10.3 Russia Platelet Rich Plasma (PRP), By End-Use
    • 8.3.11 Platelet Rich Plasma (PRP) Market - Rest of Europe
      • 8.3.11.1 Rest of Europe Platelet Rich Plasma (PRP), By Type
      • 8.3.11.2 Rest of Europe Platelet Rich Plasma (PRP), By Application
      • 8.3.11.3 Rest of Europe Platelet Rich Plasma (PRP), By End-Use
  • 8.4 Platelet Rich Plasma (PRP) Market - Asia Pacific
    • 8.4.1 Asia Pacific Platelet Rich Plasma (PRP), By Type
    • 8.4.2 Asia Pacific Platelet Rich Plasma (PRP), By Application
    • 8.4.3 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.4.4 Platelet Rich Plasma (PRP) Market - Japan
      • 8.4.4.1 Japan Platelet Rich Plasma (PRP), By Type
      • 8.4.4.2 Japan Platelet Rich Plasma (PRP), By Application
      • 8.4.4.3 Japan Platelet Rich Plasma (PRP), By End-Use
    • 8.4.5 Platelet Rich Plasma (PRP) Market - China
      • 8.4.5.1 China Platelet Rich Plasma (PRP), By Type
      • 8.4.5.2 China Platelet Rich Plasma (PRP), By Application
      • 8.4.5.3 China Platelet Rich Plasma (PRP), By End-Use
    • 8.4.6 Platelet Rich Plasma (PRP) Market - India
      • 8.4.6.1 India Platelet Rich Plasma (PRP), By Type
      • 8.4.6.2 India Platelet Rich Plasma (PRP), By Application
      • 8.4.6.3 India Platelet Rich Plasma (PRP), By End-Use
    • 8.4.7 Platelet Rich Plasma (PRP) Market - Malaysia
      • 8.4.7.1 Malaysia Platelet Rich Plasma (PRP), By Type
      • 8.4.7.2 Malaysia Platelet Rich Plasma (PRP), By Application
      • 8.4.7.3 Malaysia Platelet Rich Plasma (PRP), By End-Use
    • 8.4.8 Platelet Rich Plasma (PRP) Market - Indonesia
      • 8.4.8.1 Indonesia Platelet Rich Plasma (PRP), By Type
      • 8.4.8.2 Indonesia Platelet Rich Plasma (PRP), By Application
      • 8.4.8.3 Indonesia Platelet Rich Plasma (PRP), By End-Use
    • 8.4.9 Platelet Rich Plasma (PRP) Market - South Korea
      • 8.4.9.1 South Korea Platelet Rich Plasma (PRP), By Type
      • 8.4.9.2 South Korea Platelet Rich Plasma (PRP), By Application
      • 8.4.9.3 South Korea Platelet Rich Plasma (PRP), By End-Use
    • 8.4.10 Platelet Rich Plasma (PRP) Market - Australia
      • 8.4.10.1 Australia Platelet Rich Plasma (PRP), By Type
      • 8.4.10.2 Australia Platelet Rich Plasma (PRP), By Application
      • 8.4.10.3 Australia Platelet Rich Plasma (PRP), By End-Use
    • 8.4.11 Platelet Rich Plasma (PRP) Market - Rest of APAC
      • 8.4.11.1 Rest of APAC Platelet Rich Plasma (PRP), By Type
      • 8.4.11.2 Rest of APAC Platelet Rich Plasma (PRP), By Application
      • 8.4.11.3 Rest of APAC Platelet Rich Plasma (PRP), By End-Use
  • 8.5 Platelet Rich Plasma (PRP) Market - Latin America
    • 8.5.1 Latin America Platelet Rich Plasma (PRP), By Type
    • 8.5.2 Latin America Platelet Rich Plasma (PRP), By Application
    • 8.5.3 Latin America Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.5.4 Platelet Rich Plasma (PRP) Market - Mexico
      • 8.5.4.1 Mexico Platelet Rich Plasma (PRP), By Type
      • 8.5.4.2 Mexico Platelet Rich Plasma (PRP), By Application
      • 8.5.4.3 Mexico Platelet Rich Plasma (PRP), By End-Use
    • 8.5.5 Platelet Rich Plasma (PRP) Market - Brazil
      • 8.5.5.1 Brazil Platelet Rich Plasma (PRP), By Type
      • 8.5.5.2 Brazil Platelet Rich Plasma (PRP), By Application
      • 8.5.5.3 Brazil Platelet Rich Plasma (PRP), By End-Use
    • 8.5.6 Platelet Rich Plasma (PRP) Market - Argentina
      • 8.5.6.1 Argentina Platelet Rich Plasma (PRP), By Type
      • 8.5.6.2 Argentina Platelet Rich Plasma (PRP), By Application
      • 8.5.6.3 Argentina Platelet Rich Plasma (PRP), By End-Use
    • 8.5.7 Platelet Rich Plasma (PRP) Market - Rest of Latin America
      • 8.5.7.1 Rest of LATAM Platelet Rich Plasma (PRP), By Type
      • 8.5.7.2 Rest of LATAM Platelet Rich Plasma (PRP), By Application
      • 8.5.7.3 Rest of LATAM Platelet Rich Plasma (PRP), By End-Use
  • 8.6 Platelet Rich Plasma (PRP) Market - Middle East Africa
    • 8.6.1 Middle East & Africa Platelet Rich Plasma (PRP), By Type
    • 8.6.2 Middle East & Africa Platelet Rich Plasma (PRP), By Application
    • 8.6.3 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.6.4 Platelet Rich Plasma (PRP) Market - Saudi Arabia
      • 8.6.4.1 Saudi Arabia Platelet Rich Plasma (PRP), By Type
      • 8.6.4.2 Saudi Arabia Platelet Rich Plasma (PRP), By Application
      • 8.6.4.3 Saudi Arabia Platelet Rich Plasma (PRP), By End-Use
    • 8.6.5 Platelet Rich Plasma (PRP) Market - South Africa
      • 8.6.5.1 South Africa Platelet Rich Plasma (PRP), By Type
      • 8.6.5.2 South Africa Platelet Rich Plasma (PRP), By Application
      • 8.6.5.3 South Africa Platelet Rich Plasma (PRP), By End-Use
    • 8.6.6 Platelet Rich Plasma (PRP) Market - Rest of MEA
      • 8.6.6.1 Rest of MEA Platelet Rich Plasma (PRP), By Type
      • 8.6.6.2 Rest of MEA Platelet Rich Plasma (PRP), By Application
      • 8.6.6.3 Rest of MEA Platelet Rich Plasma (PRP), By End-Use

Chapter 9. Competitive Landscape

  • 9.1 Key Market Players: Categorization
  • 9.2 Strategy Framework
  • 9.3 Vendor Landscape
  • 9.4 Strategies Categorization
    • 9.4.1 Launch/Approval/Development

Chapter 10. Company Profiles

  • 10.1 Vivostat
    • 10.1.1 Business Overview
    • 10.1.2 Products and Services
  • 10.2 Arthrex, Inc.
    • 10.2.1 Business Overview
    • 10.2.2 Products and Services
    • 10.2.3 Recent Developments
  • 10.3 RegenOrthoSport
    • 10.3.1 Business Overview
    • 10.3.2 Products and Services
  • 10.4 Dr PRP USA LLC
    • 10.4.1 Business Overview
    • 10.4.2 Products and Services
  • 10.5 Juventix Regenerative Medical, LLC.
    • 10.5.1 Business Overview
    • 10.5.2 Products and Services
  • 10.6 Terumo Cardiovascular Systems Corporation
    • 10.6.1 Business Overview
    • 10.6.2 Financial Snapshot
      • 10.6.2.1 Revenue by Geographic Region
    • 10.6.3 Products and Services
  • 10.7 Zimmer Biomet
    • 10.7.1 Business Overview
    • 10.7.2 Financial Snapshot
      • 10.7.2.1 Net Sales by Geographic
      • 10.7.2.2 Net Sales by Product Category
    • 10.7.3 Products and Services
    • 10.7.4 Recent Developments
  • 10.8 Isto Biologics
    • 10.8.1 Business Overview
    • 10.8.2 Products and Services
    • 10.8.3 Recent Developments
  • 10.9 APEX Biologix
    • 10.9.1 Business Overview
    • 10.9.2 Products and Services
    • 10.9.3 Recent Developments
  • 10.10 Regen Lab SA
    • 10.10.1 Business Overview
    • 10.10.2 Products and Services

List of Tables

  • Table 1 Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 2 Platelet Rich Plasma (PRP) Market, By Pure Platelet-Rich Plasma (P-PRP), 2021 - 2034 (USD Million)
  • Table 3 Platelet Rich Plasma (PRP) Market, By Leukocyte-and Platelet-Rich Plasma (L-PRP), 2021 - 2034 (USD Million)
  • Table 4 Platelet Rich Plasma (PRP) Market, By Pure Platelet-Rich Fibrin (P-PRF), 2021 - 2034 (USD Million)
  • Table 5 Platelet Rich Plasma (PRP) Market, By Leukocyte- and Platelet-Rich Fibrin (L-PRF), 2021 - 2034 (USD Million)
  • Table 6 Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 7 Platelet Rich Plasma (PRP) Market, By Orthopedics, 2021 - 2034 (USD Million)
  • Table 8 Platelet Rich Plasma (PRP) Market, By Sports Medicine, 2021 - 2034 (USD Million)
  • Table 9 Platelet Rich Plasma (PRP) Market, By General Surgery, 2021 - 2034 (USD Million)
  • Table 10 Platelet Rich Plasma (PRP) Market, By Dermatology, 2021 - 2034 (USD Million)
  • Table 11 Platelet Rich Plasma (PRP) Market, By Ophthalmology, 2021 - 2034 (USD Million)
  • Table 12 Platelet Rich Plasma (PRP) Market, By Ophthalmology, 2021 - 2034 (USD Million)
  • Table 13 Platelet Rich Plasma (PRP) Market, By Cardiology, 2021 - 2034 (USD Million)
  • Table 14 Platelet Rich Plasma (PRP) Market, By Others, 2021 - 2034 (USD Million)
  • Table 15 Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 16 Platelet Rich Plasma (PRP) Market, By Hospitals, 2021 - 2034 (USD Million)
  • Table 17 Platelet Rich Plasma (PRP) Market, By Clinics, 2021 - 2034 (USD Million)
  • Table 18 Platelet Rich Plasma (PRP) Market, By Others, 2021 - 2034 (USD Million)
  • Table 19 Platelet Rich Plasma (PRP) Market Assessment, By Geography, 2021 - 2034 (USD Million)
  • Table 20 North America Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 21 North America Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 22 North America Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 23 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 24 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 25 U.S. Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 26 Canada Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 27 Canada Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 28 Canada Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 29 Europe Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 30 Europe Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 31 Europe Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 32 France Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 33 France Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 34 France Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 35 Germany Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 36 Germany Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 37 Germany Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 38 UK Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 39 UK Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 40 UK Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 41 Italy Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 42 Italy Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 43 Italy Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 44 Netherlands Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 45 Netherlands Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 46 Netherlands Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 47 Spain Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 48 Spain Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 49 Spain Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 50 Russia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 51 Russia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 52 Russia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 53 Rest of Europe Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 54 Rest of Europe Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 55 Rest of Europe Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 56 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 57 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 58 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 59 Japan Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 60 Japan Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 61 Japan Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 62 China Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 63 China Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 64 China Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 65 India Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 66 India Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 67 India Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 68 Malaysia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 69 Malaysia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 70 Malaysia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 71 Indonesia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 72 Indonesia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 73 Indonesia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 74 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 75 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 76 South Korea Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 77 Australia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 78 Australia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 79 Australia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 80 Rest of APAC Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 81 Rest of APAC Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 82 Rest of APAC Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 83 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 84 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 85 Latin America Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 86 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 87 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 88 Mexico Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 89 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 90 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 91 Brazil Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 92 Argentina Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 93 Argentina Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 94 Argentina Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 95 Rest of LATAM Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 96 Rest of LATAM Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 97 Rest of LATAM Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 98 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 99 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 100 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 101 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 102 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 103 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 104 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 105 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 106 South Africa Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 107 Rest of MEA Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 108 Rest of MEA Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 109 Rest of MEA Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)

List of Figures

  • Figure 1. Information Procurement
  • Figure 2. Primary Research Pattern
  • Figure 3. Primary research process
  • Figure 4. Market research approaches - Bottom-Up Approach
  • Figure 5. Market research approaches - Top-Down Approach
  • Figure 6. Market research approaches - Combined Approach
  • Figure 7. Executive Summary
  • Figure 8. Market by Region, 2022 (USD Million)
  • Figure 9. Platelet Rich Plasma (PRP) Market, 2021 - 2034 (USD Million)
  • Figure 10. Value Chain Analysis
  • Figure 11. Porter's Five Forces
  • Figure 12. PESTLE Analysis
  • Figure 13. Market by Type
  • Figure 14. Platelet Rich Plasma (PRP) Market, By Type, 2024 & 2034 (USD Million)
  • Figure 15. Market by Application
  • Figure 16. Platelet Rich Plasma (PRP) Market, By Application, 2024 & 2034 (USD Million)
  • Figure 17. Market by End-Use
  • Figure 18. Platelet Rich Plasma (PRP) Market, By End-Use, 2024 & 2034 (USD Million)
  • Figure 19. Platelet Rich Plasma (PRP) Market Assessment, By Geography, 2024 & 2034 (USD Million)